PARP9 and PARP14 cross-regulate macrophage activation via STAT1 ADP-ribosylation
Nature Communications,
Oct 2016
Iwata and al.
Abstract
Despite the global impact of macrophage activation in vascular disease,
the underlying mechanisms remain obscure. Here we show, with global
proteomic analysis of macrophage cell lines treated with either IFNγ or
IL-4, that PARP9 and PARP14 regulate macrophage activation. In primary
macrophages, PARP9 and PARP14 have opposing roles in macrophage
activation. PARP14 silencing induces pro-inflammatory genes and STAT1
phosphorylation in M(IFNγ) cells, whereas it suppresses
anti-inflammatory gene expression and STAT6 phosphorylation in M(IL-4)
cells. PARP9 silencing suppresses pro-inflammatory genes and STAT1
phosphorylation in M(IFNγ) cells. PARP14 induces ADP-ribosylation of
STAT1, which is suppressed by PARP9. Mutations at these ADP-ribosylation
sites lead to increased phosphorylation. Network analysis links
PARP9–PARP14 with human coronary artery disease. PARP14 deficiency in
haematopoietic cells accelerates the development and inflammatory burden
of acute and chronic arterial lesions in mice. These findings suggest
that PARP9 and PARP14 cross-regulate macrophage activation.
Construction and enforced expression of mutant STAT1
Human
pcDNA-GFP-STAT1 was purchased from Addgene (Cambridge, MA, USA).
Step-wise mutations (glutamic acid, E, to glutamine, Q) was introduced
at the two ribosylation sites flanking the phosphorylation at
Tyr701—E657 and E705—by recombinant PCR mutagenesis. Mutated constructs
were verified by DNA sequencing. Mouse bone marrow macrophages were
differentiated from bone marrow stromal cells using 10 ng ml−1
M-CSF for 12 days. pcDNA-GFP-STAT1 (WT) and the mutant pcDNA-GFP-STAT1
E657Q, E705Q, were transferred by Magnetofection (OzBiosciences, San
Diego, CA, USA). HEK293 cells were transfected using Lipofectamine LTX
(Invitrogen, USA). Twenty-four hours after transfection, cells were
serum-starved (0.1% FBS) for 2 h and stimulated with IFNγ for 1 h
(phospho-STAT1) or 24 h (mRNA expression of pro-inflammatory factors).
The overexpressed STAT1 was immunoprecipitated using anti-GFP antibody,
clone 9F9.F9 (1:1,000, ab1218, Abcam). STAT1 phosphorylation at Tyr 701
was detected by anti-phospho-STAT1 (Tyr701; 1:1,000, mAb #7649, Cell
Signaling). Antibodies against STAT1 (ab3987, Abcam) and GFP (ab290,
Abcam) served as loading controls. Transfection into THP-1 cells was
performed using the magnetofection method described above.
No comments:
Post a Comment